189 related articles for article (PubMed ID: 6111984)
1. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
Lawson JW; Wojciechowski NJ
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of quinidine-propranolol elevation of the ventricular fibrillation threshold by bilateral stellectomy+vagotomy in the anesthetized dog.
Lawson JW
Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):74-83. PubMed ID: 3718083
[TBL] [Abstract][Full Text] [Related]
3. The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
Lawson JH; Wojciechowski NJ
Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):235-43. PubMed ID: 596978
[TBL] [Abstract][Full Text] [Related]
4. Effect of some beta adrenergic blocking agents and phenytoin on potentiation of quinidine antiarrhythmic activity in the mouse.
Lawson JW
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):106-15. PubMed ID: 6149731
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
[TBL] [Abstract][Full Text] [Related]
6. Interaction of quinidine and propranolol in experimental cardiac arrhythmias in the dog.
Madan BR; Pendse VK
Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):287-93. PubMed ID: 849075
[TBL] [Abstract][Full Text] [Related]
7. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
[TBL] [Abstract][Full Text] [Related]
8. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.
Iansmith DH; Bandura JP; Nash CB
J Pharmacol Exp Ther; 1981 Dec; 219(3):651-8. PubMed ID: 7299688
[No Abstract] [Full Text] [Related]
9. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
Gautam CS; Sharma PL; Pandhi P
Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
[TBL] [Abstract][Full Text] [Related]
10. Interaction of quinidine and propranolol on vulnerability of the ventricle to electrical fibrillation.
Lawson JW; Wojciechowski NJ
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):231-41. PubMed ID: 4827411
[No Abstract] [Full Text] [Related]
11. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
Baker T; Erker EF
Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
[TBL] [Abstract][Full Text] [Related]
12. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Patterson E; Lucchesi BR
Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
[TBL] [Abstract][Full Text] [Related]
13. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
Shimotori M; Kobayashi M; Chiba S
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
[TBL] [Abstract][Full Text] [Related]
14. The effect of the combination of quinidine and propranolol upon atrial and ventricular automatically in dogs.
Korte DW; Nash CB
J Pharmacol Exp Ther; 1978 Feb; 204(2):303-11. PubMed ID: 340642
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic activity of some isoquinoline derivatives determined by a rapid screening procedure in the mouse.
Lawson JW
J Pharmacol Exp Ther; 1968 Mar; 160(1):22-31. PubMed ID: 4966361
[No Abstract] [Full Text] [Related]
16. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
Kaplan HR; Commarato MA
J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
[No Abstract] [Full Text] [Related]
17. Elevation of ventricular fibrillatory threshold by beta-adrenergic blocking agents.
Baum T; Peters JR; Eckfeld DK; Varner LL; Dinish J; Metz N; Shropshire AT
Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):292-300. PubMed ID: 4405153
[No Abstract] [Full Text] [Related]
18. Beta-adrenergic blockade and antiarrhythmic activity of (-)- and (+)-propranolol.
Flórez J; Pomar JL; Malpartida F
Rev Esp Fisiol; 1969 Dec; 25(4):287-92. PubMed ID: 4401670
[No Abstract] [Full Text] [Related]
19. K+ channel blockade in the prevention of ventricular fibrillation in dogs with acute ischemia and enhanced sympathetic activity.
Vanoli E; Hull SS; Adamson PB; Foreman RD; Schwartz PJ
J Cardiovasc Pharmacol; 1995 Dec; 26(6):847-54. PubMed ID: 8606519
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of sotalol and propranolol on myocardial contractility.
Gomoll AW; Braunwald E
Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
